The Personalized Medicine World Conference (PMWC) 2011 is a two-day business and educational conference and is a follow-on to the sold-out PMWC 2010, held last January and the PMWC Israel this past June.
Join the leaders and innovators of personalized medicine on January 18-19 in Silicon Valley at the PMWC 2011,
Learn how personalized medicine is transforming health care at this integrated conference and gain insight into breakthrough technologies, the latest research and new regulation issues developing within the personalized medicine landscape.
Who will be there?
Academic thought leaders, bio-pharma executives, entrepreneurs, institutional and private investors, healthcare providers, payers and government policy makers.
CLICK HERE TO VIEW THE PROGRAM
Partial list of speakers:
Mara Aspinall, On-Q-ity, Inc.
Alexis Borisy, Foundation Medicine, Inc.
Lynda Chin, Dana-Farber Cancer Institute
Michael Christman, Coriell Institute
George Church, Harvard University
Jeffrey Gibbs, Hyman, Phelps & McNamara
Jesse Goodman, FDA
Lee Hood, Institute for Systems Biology
Paul Kearney, Integrated Diagnostics
Clifton Ling, Varian
George Lundberg, Medscape
Clay Marsh, Ohio State University
Garry Nolan, Stanford University
Vicki Seyfert-Margolis, FDA
Ralph Snyderman, Duke University
Patrick Terry, Technic Solution
REGISTER by September 15th and save 50% off registration (regular:$1000).
Fully-refundable by 11/15.
Special SUPER EARLY BIRD discount is available for two weeks ONLY! (expires September 15th)
The PMWC promotes the accelerated adoption of Personalized Medicine on a global-scale, acting as the nexus between research, academia, investment, industry and the entrepreneurial spirit of Silicon Valley. The Conference includes sessions covering the latest advances in clinical practice, regulation and the economics of Personalized Medicine.
During the last year, several new and existing start-ups in the field have raised significant venture funds. Novel molecular diagnostics and targeted drugs are moving through the regulatory approval pipeline and promising new treatment options are becoming available. Personalized Medicine is revolutionizing health-care and transforming the traditional patient-physician relationship as patients are becoming empowered to actively participate in making clinical decisions.
Exhibition, Parallel Company Presentations and Company Award Competition will feature select companies recognized for their breakthrough products and services. In the final stage, Top 3 companies will present in front of an Award Panel and the audience, one of which will be chosen as the PMWC Israel Most Promising Company Award 2011.
The PMWC Israel Most Promising Company Winner: Applied Immune Technologies (AIT), a drug development company specializing in T-Cell Receptor-Like (TCRL) antibodies.